Determining a Tolerable Dose of Primaquine in G6PD-deficient Persons Without Malaria in Mali

NCT02535767 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
28
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of California, San Francisco

Collaborators